Pharmaleaders TV
You are here:  / Business / Profiles / R & D / SMILES International Institute of Coloproctology – 1st Hospital in India to use Mayo Clinic Developed M-Compass for Anorectal Manometry Test

SMILES International Institute of Coloproctology – 1st Hospital in India to use Mayo Clinic Developed M-Compass for Anorectal Manometry Test

SMILES International Institute of Coloproctology is the first hospital in India to use anorectal manometry technology developed by Mayo Clinic USA. The Mayo Clinic designed and manufactured M-Compass is an FDA approved anal manometry device. Using an M-Compass, the Anorectal Manometry Test (ARM) is performed to evaluate patients with fecal incontinence/chronic constipation. Today millions suffer from fecal incontinence and constipation while access to manometry equipment is limited. Easier access to M-Compass can put many suffering from fecal incontinence/chronic constipation on the road to recovery and drastically improve their lives.  

The M-Compass device is portable, wireless, and weighs only 3 lbs. It is easy to use, affordable and can be used in a doctor’s office. Conventional ARMs are huge, aren’t portable, and can only be used in a dedicated room. The M-Compass is also simple to setup, consists of only 3 components, and has built in software guidance while conventional ARMs are large complicated systems.

Prior to performing an ARM using an M-Compass, no bowel preparation is required and there is no need to restrict one’s diet. Also patients who undergo an ARM using an M-Compass are not required to discontinue routine medication. An advantage of the Anorectal Manometry Test is, when it is used along with adjunctive tests, it can not only confirm a clinical diagnosis but also provide new information that cannot be clinically detected. It can also influence the outcome of patients suffering from incontinence/chronic constipation. Patients who have been tested so far using the M-Compass are highly satisfied. 

Speaking about how people will benefit from the M-Compass Dr. Parameshwara CM said “This innovative technology will allow people across India to be tested more accurately than ever before. Using M-Compass an ARM can be completed in as little as 5 minutes. Of the millions across India who suffer from incontinence/chronic constipation, many will be greatly helped by M-Compass. We believe that bringing this technology to the masses so that millions can live more comfortable and happier lives is needed. We’re proud to be the first hospital in India to do so”.

PHARMALEADERS

Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in the healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry.

LEAVE A REPLY

Your email address will not be published. Required fields are marked ( required )

This site uses Akismet to reduce spam. Learn how your comment data is processed.

February 2019
M T W T F S S
« Dec    
 123
45678910
11121314151617
18192021222324
25262728  
Follow us
Contact us

Network 7 Meadia Group

Plot 5, NS Road No. 12, JVPD, Juhu Scheme, Mumbai, Maharashtra 400049. debashish.mishra@network7mediagroup.com